FDA Approves GLP-1 Pill for Primary, Secondary Cardiovascular Protection
(MedPage Today) — The FDA approved oral semaglutide (Rybelsus) to prevent major adverse cardiovascular events (MACE) in high-risk patients with diabetes, whether or not they’ve had such an event already, Novo Nordisk announced. Semaglutide 7…
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest Physicians, held from Oct. 19 to 22 in Chicago.
CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA
MONDAY, Oct. 20, 2025 — Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA)…
American Airlines Cuts Ozempic From Flight Attendant Healthcare Coverage
American Airlines’ flight attendant union is expressing frustration over an upcoming change to the company’s healthcare plan, as flagged by PYOK. I’m curious to see how this plays out. American angers union with 2026 healthcare changes The Association of Professional Flight Attendants (APFA) isn’t happy about some changes that American is making to employee healthcare […]
Can Sculptra reverse GLP-1-related facial ageing? Experts say yes
New data presented at AMWC Dubai highlights Sculptra’s regenerative effects and its synergy with Restylane to address GLP-1-related facial ageing. Discover expert insights and clinical findings.
Supreme bets on GLP-1 users with SlimFast acquisition
Post Content
GLP-1 drug approvals: A breakdown
As of Oct. 17, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications. The approved indications for brand-name GLP-1s: Bydureon (exenatide) Type 2 diabetes in patients ages 10 years and older Byetta (exenatide) Type 2 diabetes in adults Mounjaro (tirzepatide) Type 2 diabetes […]
How GLP-1 drugs are supercharging the age of precision nutrition
As GLP-1 weight-loss drugs like Ozempic reshape how consumers eat, food and beverage manufacturers are racing to develop precision nutrition solutions – using AI and functional ingredients to personalise diets and target metabolism more effectively.
The GLP-1 Economy Is Crashing. CVS Ventures Is Quietly Building What Comes Next
As the GLP-1 economy cools, CVS Ventures leads a $25 million round in Knownwell — betting on physician-led obesity care and payer-backed innovation.
Could functional foods replace the need for GLP-1s?
Explore how functional ingredients are challenging GLP-1 drugs in weight management – and what this shift means for food and beverage innovation.